Today: 8 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Nuvation Bio (NUVB) Soars After $18 Price-Target Hike – Is This High‑Growth Cancer Stock Still a Buy in 2025?

Nuvation Bio (NUVB) Soars After $18 Price-Target Hike – Is This High‑Growth Cancer Stock Still a Buy in 2025?

Nuvation Bio Inc. (NYSE: NUVB) has quietly morphed from an obscure penny stock into one of 2025’s wildest oncology stories. As of December 11, 2025, the stock is trading in the high single digits (around $7.8–$8.0), up roughly 200% year‑to‑date, following a string of clinical wins, a first drug approval, and a wave of fresh analyst upgrades. TipRanks+1 The latest jolt came today, when H.C. Wainwright raised its 12‑month price target on NUVB from $10 to $18 while reiterating a Buy / Strong Buy rating – implying well over 100% upside from recent levels. Investing.com+1 Here’s a deep dive into
11 December 2025
First Majestic Silver (AG) Blasts to a 52‑Week High as Silver Hits Records – Can the Run Last?

First Majestic Silver (AG) Blasts to a 52‑Week High as Silver Hits Records – Can the Run Last?

December 11, 2025 First Majestic Silver Corp. (NYSE: AG; TSX: AG) is suddenly one of the loudest tickers in the precious‑metals choir. The silver miner’s stock has surged to a new 52‑week high and is riding a powerful cocktail of record production, rising cash flow, ultra‑cheap debt financing and a silver price that just punched to all‑time highs. Not to be confused with insurance giant American International Group, Inc., First Majestic is a pure play on silver (with a gold side‑quest) operating mines in Mexico and development assets in North America.StockAnalysis+1 AG Stock Today: New Highs and a Triple‑Digit Rally
11 December 2025
·
Oracle Stock Crashes 14% as Wall Street Slashes AI Price Targets

Oracle Stock Crashes 14% as Wall Street Slashes AI Price Targets

Oracle Corporation’s aggressive bet on artificial intelligence and cloud infrastructure just ran into its first serious market backlash. On Thursday, December 11, 2025, Oracle stock (NYSE: ORCL) plunged around 13–14% in U.S. trading, erasing more than $100 billion in market value in a single session and marking its worst one‑day drop since the early 2000s.Barron’s+2The Economic Times+2 The selloff came after the company’s latest fiscal second‑quarter results showed booming AI‑driven cloud demand — but also record capital spending, negative free cash flow and guidance that fell short of sky‑high expectations. Within hours, a wave of Wall Street banks cut their
11 December 2025
·
Centene (CNC) Stock Jumps on Baird Upgrade: What December 11, 2025 Means for the Outlook and Forecasts

Centene (CNC) Stock Jumps on Baird Upgrade: What December 11, 2025 Means for the Outlook and Forecasts

Centene Corporation (NYSE: CNC) has snapped back into the spotlight. On December 11, 2025, Centene stock surged above $40 after Robert W. Baird lifted its price target from $28 to $36 while maintaining a neutral rating. The move added to a sharp multi-week rebound following a brutal summer of guidance cuts, goodwill impairments and a rare quarterly loss. MarketBeat+1 At Thursday’s close, CNC traded around $40.73, up roughly 5.3% on the day, with an intraday high near $40.90. MarketBeat That rally puts shares about 62% above their 52‑week low of $25.08, but still roughly 39% below the 52‑week high of
11 December 2025
·
Vera Therapeutics (VERA) Stock Outlook: December 11, 2025 Update on Public Offering, Atacicept BLA and Wall Street Targets

Vera Therapeutics (VERA) Stock Outlook: December 11, 2025 Update on Public Offering, Atacicept BLA and Wall Street Targets

Vera Therapeutics, Inc. (NASDAQ: VERA) is back center stage on December 11, 2025, as traders digest a fresh equity offering, strong late‑stage clinical data, and a newly filed Biologics License Application (BLA) for its lead drug, atacicept, in IgA nephropathy (IgAN). During Thursday’s session, VERA shares were trading around $46, up roughly 3–4% on the day and near 52‑week highs, leaving the company with a market capitalization of about $2.9–3.0 billion.Stock Titan Below is a full rundown of the latest news, forecasts, and analysis as of December 11, 2025. Vera Therapeutics stock today: price action and technical backdrop VERA has
11 December 2025
·
Arrowhead Pharmaceuticals (ARWR) Stock Near 52‑Week High After FDA Approval and New Alzheimer’s Trial: Latest News & Forecasts as of December 11, 2025

Arrowhead Pharmaceuticals (ARWR) Stock Near 52‑Week High After FDA Approval and New Alzheimer’s Trial: Latest News & Forecasts as of December 11, 2025

Arrowhead Pharmaceuticals (NASDAQ: ARWR) has quietly turned into one of 2025’s wildest biotech comeback stories. After years as a perpetually “promising” RNA interference (RNAi) platform, the company now has: The stock price has responded in full drama mode. As of the afternoon of December 11, 2025, Arrowhead shares are trading around $70, having touched intraday highs above $72 and notching a new 52‑week high in the low‑$70s. Investing.com+1 Over the last month, the stock has climbed from the low‑$40s to roughly $70 — a gain on the order of three‑quarters in just a few weeks. Investing.com At today’s levels, Arrowhead’s
11 December 2025
··
Immunovant (IMVT) Stock Jumps After $550 Million Share Offering as Graves’ Disease Launch Comes Into Focus

Immunovant (IMVT) Stock Jumps After $550 Million Share Offering as Graves’ Disease Launch Comes Into Focus

NEW YORK – December 11, 2025 – Shares of Immunovant, Inc. (NASDAQ: IMVT) were sharply in focus on Thursday after the clinical‑stage immunology company announced a $550 million common stock financing designed to fund development and a potential commercial launch of its lead FcRn inhibitor, IMVT‑1402, in Graves’ disease.Immunovant, Inc.+1 By late afternoon, Immunovant stock was trading around $25.75, up roughly 9% on the day, with an intraday range between $22.03 and $25.87, giving the company a market value of about $4 billion.Stock Titan That upbeat finish came despite an initial sell‑off; one early report noted shares dropped around 7%
11 December 2025
····
Coeur Mining (CDE) Stock on December 11, 2025: Palmarejo Breakthroughs, $7B New Gold Deal and What Comes Next

Coeur Mining (CDE) Stock on December 11, 2025: Palmarejo Breakthroughs, $7B New Gold Deal and What Comes Next

Updated: December 11, 2025 Coeur Mining, Inc. (NYSE: CDE) has turned into one of 2025’s most dramatic comeback stories in precious metals. The U.S.-based gold‑and‑silver producer has delivered record cash flow, launched its largest exploration push in more than a decade, and unveiled a $7 billion all‑stock acquisition of New Gold Inc. that would create a new North American mining heavyweight. Coeur Mining+2Proactiveinvestors NA+2 At the same time, the stock has gone from forgotten mid‑cap to momentum darling. On December 11, 2025, CDE is trading around $16.84 per share, up roughly 5% intraday, with a session range between about $15.89
11 December 2025
···
Roku Stock Jumps on Fresh Analyst Upgrades: Is NASDAQ:ROKU Setting Up for a 2026 Breakout?

Roku Stock Jumps on Fresh Analyst Upgrades: Is NASDAQ:ROKU Setting Up for a 2026 Breakout?

Roku, Inc. (NASDAQ: ROKU) is back on center stage. On Thursday, December 11, 2025, the streaming platform’s stock is trading around the $109–110 mark, up strongly on the day and hovering near the top of its 52‑week range of roughly $52 to $117.Investing.com+1 A wave of new analyst calls, upbeat earnings trends, and a clearer path to profitable growth are now reshaping how Wall Street looks at Roku stock going into 2026. Roku Stock Today: Price, Momentum and Market Context Across major data providers, Roku’s share price sits in the low $100s, with today’s session pushing it close to the
11 December 2025
·
Belite Bio (NASDAQ: BLTE) Stock: DRAGON Trial Breakthrough, $350 Million Offering and Outlook After a 130% Rally

Belite Bio (NASDAQ: BLTE) Stock: DRAGON Trial Breakthrough, $350 Million Offering and Outlook After a 130% Rally

Belite Bio, Inc. (NASDAQ: BLTE) has turned into one of 2025’s most closely watched biotech stories. On the back of a pivotal Phase 3 win in Stargardt disease and a large equity raise, the small-cap ophthalmology specialist has seen its share price more than double this year and its market value climb into the multi‑billion‑dollar range.BioPharma Dive+1 As of the afternoon of December 11, 2025, Belite Bio stock is trading around $154 per share, up roughly 4–5% on the day and more than 130% year‑to‑date, giving the company a market capitalization of roughly $5–6 billion.Stock Titan+1 The rally has pushed
11 December 2025
·
Wayfair (W) Stock Nears $100 as Hedge Funds Buy and Jefferies Turns Cautious – December 11, 2025 Outlook & Forecast

Wayfair (W) Stock Nears $100 as Hedge Funds Buy and Jefferies Turns Cautious – December 11, 2025 Outlook & Forecast

Wayfair Inc. (NYSE: W) is back in the market spotlight. As of Thursday, December 11, 2025, the online home-goods retailer’s stock is trading around $99–100 per share, up roughly 7% on the day from a prior close near $93.³Investing.com That move caps a roller-coaster year in which Wayfair has: Today’s story is a tug‑of‑war: hedge funds are buying, insiders have been selling, and analysts are sharply divided between rich upside and cooling enthusiasm. Below is a breakdown of the key news, forecasts, and analyses dated December 11, 2025, and how they fit into the bigger picture for Wayfair stock. Wayfair
11 December 2025
··
Unity Software (NYSE: U) Stock Outlook: Analyst Upgrades, Q3 Beat and 2026 Forecasts Fuel a High‑Beta Rally

Unity Software (NYSE: U) Stock Outlook: Analyst Upgrades, Q3 Beat and 2026 Forecasts Fuel a High‑Beta Rally

Updated: December 11, 2025 Unity Software Inc. (NYSE: U) has turned into one of 2025’s loudest comeback stories in software. After collapsing from its 2021 metaverse peak and alienating game developers with a disastrous pricing overhaul, the stock has roared back on the back of an AI‑driven ad business, tighter cost control and a wall of bullish analyst calls. As of late-morning trading on December 11, Unity shares are hovering around $51, near a fresh 52‑week high, giving the company a market cap of roughly $22 billion. StockAnalysis+1 That rally has invited a simple but uncomfortable question: is Unity now
11 December 2025
Upwork (UPWK) Stock Hits Fresh 52‑Week High: AI Partnerships, Index Inclusion and Q3 Earnings Rewire the 2026 Outlook

Upwork (UPWK) Stock Hits Fresh 52‑Week High: AI Partnerships, Index Inclusion and Q3 Earnings Rewire the 2026 Outlook

Upwork Inc. (NASDAQ: UPWK) has quietly turned into one of the more interesting AI-adjacent small-cap stories on the market. As of December 11, 2025, the online work marketplace is trading around new 52‑week highs near $21–22 per share, after a run of positive news: record Q3 results, long‑term growth targets, strategic AI partnerships, entry into the S&P SmallCap 600, and a new international AI hub in Lisbon. Investing.com Canada+1 At the same time, heavy insider selling, elevated short interest and concerns about AI replacing some freelance work are keeping the bear case alive. That mix of euphoria and anxiety is
11 December 2025
····
Roivant Sciences (ROIV) Stock Surges After 2025 Investor Day: Pipeline Milestones, Cash Runway and Analyst Forecasts

Roivant Sciences (ROIV) Stock Surges After 2025 Investor Day: Pipeline Milestones, Cash Runway and Analyst Forecasts

December 11, 2025 – Roivant Sciences Ltd. (Nasdaq: ROIV) has just given Wall Street a dense dose of biotech optimism. Here’s what today’s Investor Day and the latest data mean for the stock. ROIV stock today: rally near 52‑week highs Roivant shares traded around the low‑$20s on December 11, with intraday prices near $21.5 according to real‑time market data. That move builds on a powerful run: The immediate catalyst for today’s jump: Roivant’s 2025 Investor Day, where management laid out an aggressive roadmap of 3+ potential product launches, 4+ expected NDA/BLA filings, and 8+ pivotal readouts over the next three
11 December 2025
Brinker International (EAT) Stock: Fresh News, Analyst Forecasts and Turnaround Outlook as of December 11, 2025

Brinker International (EAT) Stock: Fresh News, Analyst Forecasts and Turnaround Outlook as of December 11, 2025

Brinker International, Inc. (NYSE: EAT) — the parent of Chili’s Grill & Bar and Maggiano’s Little Italy — is back in the market spotlight. On December 11, 2025, Brinker shares are trading around $146, up roughly 7% intraday, after bouncing between $135.85 and $146.00 so far in today’s session. That puts the stock about 24% below its 52‑week high near $192 and roughly 46% above its 52‑week low around $100, underscoring how volatile the turnaround story has been for investors over the past year. Investing.com+1 Company snapshot: a Chili’s‑powered turnaround Brinker operates more than 1,600 restaurants worldwide under the Chili’s
11 December 2025
··
Lemonade (LMND) Stock Soars to 52-Week High on Tesla Integration and Q3 2025 Beat: Is the Rally Sustainable?

Lemonade (LMND) Stock Soars to 52-Week High on Tesla Integration and Q3 2025 Beat: Is the Rally Sustainable?

Lemonade, Inc. (NYSE: LMND), the AI‑driven insurance company, is back in the market’s spotlight. As of December 11, 2025, the stock is trading in the low-$80s after touching a fresh 52‑week high around $84.5, up dramatically from its 52‑week low in the mid‑$20s. Investing.com+1 The surge follows a powerful combination of accelerating growth, improving loss ratios, an ambitious path-to-profitability timeline, and a high‑profile integration with Tesla vehicles that pushes Lemonade deeper into the auto insurance market. Lemonade+1 At the same time, Wall Street’s price targets and valuation models are flashing caution, even as traditional giants like American International Group, Inc.
11 December 2025
····
Broadcom (AVGO) Stock on December 11, 2025: AI Giant Faces Earnings Test, VMware Scrutiny and Sky‑High Expectations

Broadcom (AVGO) Stock on December 11, 2025: AI Giant Faces Earnings Test, VMware Scrutiny and Sky‑High Expectations

Broadcom Inc. (NASDAQ: AVGO) heads into its fiscal Q4 2025 earnings day sitting near all‑time highs, flush with AI demand, and under fresh regulatory fire in Europe. For investors, Broadcom stock is now the purest large‑cap bet on custom AI chips and enterprise software — but also one of the most “priced for perfection” names in the market. Below is a detailed, news‑driven and forward‑looking look at AVGO as of December 11, 2025, suitable for readers following Google News and Discover. Broadcom stock today: near records after a massive 2025 rally As of early U.S. afternoon trading on December 11,
11 December 2025
·····
Rhythm Pharmaceuticals (RYTM) Hits Record High on Rare-Disease Breakthrough: Latest News, Stock Forecast and Analyst Outlook

Rhythm Pharmaceuticals (RYTM) Hits Record High on Rare-Disease Breakthrough: Latest News, Stock Forecast and Analyst Outlook

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stock is on a tear. On 11 December 2025, shares surged to a new all‑time high after the company reported encouraging mid‑stage data in Prader‑Willi syndrome (PWS) and investors refocused on a growing obesity franchise built around its melanocortin‑4 receptor (MC4R) agonist, IMCIVREE (setmelanotide).Investing.com+1 As of Thursday morning, RYTM was trading around $121 per share, up more than 15% on the day according to real‑time data from MarketBeat, and roughly 80–90% higher year‑to‑date.MarketBeat+2Investing.com+2 For a mid‑cap biotech that is still loss‑making, that kind of move demands a closer look at what changed, what analysts expect
11 December 2025
·
Perpetua Resources (PPTA) Stock: Defense-Backed Gold Miner Rides New Antimony Deal and Institutional Buying

Perpetua Resources (PPTA) Stock: Defense-Backed Gold Miner Rides New Antimony Deal and Institutional Buying

Perpetua Resources Corp. (NASDAQ: PPTA, TSX: PPTA) has moved from niche developer to one of the most closely watched names in the U.S. critical minerals space. On December 11, 2025, the stock is trading in the high‑$20s on Nasdaq after a three‑month rally of roughly 55%, fuelled by a series of funding wins, federal permits and, most recently, a new partnership with Idaho National Laboratory (INL) to pilot military‑grade antimony processing. Yahoo Finance+1 At the same time, fresh institutional ownership, new leadership hires and a thick stack of analyst reports and AI‑driven forecasts have turned Perpetua into a battleground between
11 December 2025
···
Credo Technology Group (CRDO) Stock: 7% Pullback, Fresh Institutional Buying and New Price Targets on December 11, 2025

Credo Technology Group (CRDO) Stock: 7% Pullback, Fresh Institutional Buying and New Price Targets on December 11, 2025

Date: December 11, 2025 Key takeaways CRDO stock today: volatility after a huge AI‑driven run In Thursday’s session, Credo Technology Group Holding Ltd (NASDAQ: CRDO) is trading around $154–$158 per share, with real‑time data showing a last trade near $154.50, down about 2% on the day. The company’s market capitalization sits around $32.5 billion, with a trailing price‑to‑earnings ratio north of 150 and earnings per share of $1.16. The weakness follows a sharp 7.47% drop on Wednesday, when CRDO fell from $170.29 to $157.57 in highly volatile trading, with an intraday range between $155.50 and $169.64. An AInvest note framed
11 December 2025
··
1 … 430 431 432 433 434 … 535

Stock Market Today

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

8 February 2026
Tower Semiconductor shares rose 7.7% to $139.04 Friday after announcing a collaboration with Nvidia on AI data-center networking. The stock touched $141 intraday and gained another 1% after hours. Investors await Tower’s Feb. 11 earnings for details on its silicon photonics work. No financial terms or shipment timeline were disclosed.
Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

8 February 2026
Longsys disclosed new guarantees for a 100 million yuan Hong Kong loan and a $9 million Brazil credit line, bringing its total approved guarantee quota to 11 billion yuan and outstanding guarantees to 5.81 billion yuan. The company said all guarantees are for consolidated subsidiaries and within approved limits. Shares closed at 288 yuan Friday, down 1.6%. China inflation and credit data are due this week.
MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

8 February 2026
MACOM shares rose 3.5% to $235.87 Friday after the company reported fiscal Q1 revenue of $271.6 million and raised its full-year data center growth outlook to 35–40%. Fidelity’s FMR LLC disclosed a 10.7% stake, while shareholder Susan Ocampo filed to potentially sell up to 100,000 shares. Stifel raised its price target to $255. MACOM expects to repay $161 million in convertible notes in March.
Go toTop